Immutep Financial Statements From 2010 to 2025
| IMMP Stock | USD 2.93 0.08 2.66% |
Check Immutep financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immutep's main balance sheet or income statement drivers, such as , as well as many indicators such as . Immutep financial statements analysis is a perfect complement when working with Immutep Valuation or Volatility modules.
Check out the analysis of Immutep Correlation against competitors. Immutep Ltd ADR Company Operating Margin Analysis
Immutep's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Immutep Operating Margin | (20.35) % |
Most of Immutep's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immutep Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Immutep Ltd ADR has an Operating Margin of -20.3547%. This is 41.98% lower than that of the Biotechnology sector and 81.84% lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Immutep Ltd ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Immutep's current stock value. Our valuation model uses many indicators to compare Immutep value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immutep competition to find correlations between indicators driving Immutep's intrinsic value. More Info.Immutep Ltd ADR is rated third overall in return on equity category among its peers. It also is rated third overall in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Immutep by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Immutep Financial Statements
Immutep shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Immutep investors may analyze each financial statement separately, they are all interrelated. The changes in Immutep's assets and liabilities, for example, are also reflected in the revenues and expenses on on Immutep's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Pair Trading with Immutep
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.Moving against Immutep Stock
| 0.49 | PYC | Physiomics Plc | PairCorr |
| 0.44 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.44 | DTIL | Precision BioSciences | PairCorr |
| 0.38 | JUMP | Leveljump Healthcare Corp | PairCorr |
| 0.36 | RAC | Race Oncology | PairCorr |
The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.
The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.